CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Walleye Trading LLC | 9,900 | $294,426 | 0.00% |
| Citadel Advisors | 82,600 | $2,456,524 | 0.00% |
| Citadel Advisors | 159,236 | $4,735,679 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 121,500 | $3,613,410 | 0.00% |
| GTS SECURITIES LLC | 13,874 | $412,613 | 0.00% |
| DekaBank Deutsche Girozentrale | 11,300 | $333 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,564 | $46,513 | 0.00% |
| SIGNATUREFD, LLC | 501 | $14,900 | 0.00% |
| FEDERATED HERMES, INC. | 24 | $714 | 0.00% |
| Citadel Advisors | 33,900 | $1,008,186 | 0.00% |
| Daiwa Securities Group Inc. | 199 | $6 | 0.00% |
| CWM, LLC | 60 | $2 | 0.00% |
| HAP Trading, LLC | 42,500 | $4 | 0.00% |
| Amundi | 1,820 | $52,980 | 0.00% |
| Covestor Ltd | 6 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,900 | $889,226 | 0.00% |
| JPMORGAN CHASE & CO | 54,430 | $1,618,748 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 51,792 | $1,540,294 | 0.00% |
| Russell Investments Group, Ltd. | 14 | $416 | 0.00% |
External links
This page lists CRINETICS PHARMACEUTICALS IN's shareholders in Q3 2023. To view CRINETICS PHARMACEUTICALS IN's shareholder history, click here.